comparemela.com

Latest Breaking News On - Hypertension institute - Page 1 : comparemela.com

Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Strong commercial performance of IBSRELA continues, ending FY 2023 with $80.1 million in net product sales revenue; 2024 net product sales revenue currently expected to be between $140.0 to $150.0

United statesCaitlin lowieArnold silvaMike raabPhilip schoenfeldDavid spiegelFosun pharmaCompany annual report on formInvestment corpBoise kidney hypertension instituteJapanese ministry of healthAmerican society of nephrology kidney weekExchange commissionDrug administrationExchange commission onJohnd dingell va medical center

Fasting-Mimicking Diet Provides Unique Cardiovascular Benefits: Study

Fasting-mimicking diet provides unique cardiovascular benefits compared to the Mediterranean diet, which is associated with reduced risk of heart disease, a new study has revealed.

United statesHypertension instituteHealthy livingFasting mimicking dietMediterranean dietCardiovascular benefits

Fasting-mimicking diet shows unique benefits in cardiovascular health, study finds

Study compares the fasting-mimicking diet and the Mediterranean diet in reducing cardiovascular disease risk among obese adults with hypertension, revealing unique benefits of each diet.

United statesNeha mathurNeha mathurdecSophia coveneyHypertension instituteNpj metabolic healthFoxys forest manufactureProtein unstable lesion signatureCardiovascular diseaseClinical trialOlive oil

Ardelyx (ARDX) Reports Positive Data from Studies of XPHOZAH

Ardelyx (ARDX) Reports Positive Data from Studies of XPHOZAH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDerek forfangDavid spiegelTenapanor monotherapyLaura williamsArnold silvaDrug administration onAmerican society of nephrologyBoise kidney hypertension instituteArdelyx incPennsylvania convention centerArdelyx patient advisory councilAmerican societyKidney weekExhibitor spotlightDrug administration

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesArnold silvaTenapanor monotherapyFosun pharmaDerek forfangDavid spiegelLaura williamsCaitlin lowieKimia keshtbodBoise kidney hypertension instituteArdelyx incPennsylvania convention centerArdelyx patient advisory councilAmerican society of nephrologyDrug administration onAmerican society

vimarsana © 2020. All Rights Reserved.